WEST HANTS, N.S. — The Windsor-West Hants Industrial Park will soon have a new tenant, just in time for Canada’s plan to legalize marijuana.
Creso Pharma, a publicly traded company based in Australia, is hoping that the impending legalization of marijuana in Canada, will be a boon for its growing cannabis industry, which includes supplying recreational and medical marijuana products.
Although the company has yet to confirm directly to the Valley Journal-Advertiser the location of the facility, construction of a large structure on Ivey Lane is emblazoned with the Creso Pharma logo.
A PDF on the company’s website also details progress of the new, 20,000-square-foot facility in Nova Scotia, Canada, with images that match the Windsor-West Hants Industrial Park location.
“We are very pleased that construction of the production facility is progressing well with site works such as the formation of roads and driveways and land excavation now complete as well as the installation of services including water, sewer, drainage and power,” Creso Pharma co-founder and chief executive officer Dr. Miri Halperin Wernli said in the press release.
“The Canadian market represents a significant opportunity for Creso and we look forward to completing construction by Q3 2018 which will allow us to capitalise on the huge market opportunity in Canada once recreational cannabis is legalised in addition to medicinal cannabis.”
Creso’s expansion into Canada was made possible after acquiring Mernova Medicinal Inc., a Nova Scotia-based company, which is now a subsidiary of Creso.
According to documents on Creso’s website, the facility is expected to be complete around July 2018, when the federal government is expected to pass its cannabis legalization bill, and legal, recreational marijuana will be available to the public.
Information on the site says Mernova Medicinal Inc. is working with federal and provincial governments to best position its branding, packaging and marketing to line up with anticipated guidelines.
Documents on Creso’s website say that Mernova is actively recruiting key personnel, although the number of employees that would work at this facility is unknown at this time.
Once completed, the facility is expected to produce between 2,000 and 4,000 kilograms of cannabis annually.
RELATED
- Liverpool facility granted medical marijuana licence
- Nova Scotia’s first medical marijuana facility on target in Truro
And the facility could grow in size in the future.
According to the document, Creso and Mernova have also agreed to exercise the right of first refusal option on the adjoining land parcel to allow Mernova to expand the facility to up to 200,000 square feet. The company says this will allow the facility to scale with demand, once cannabis is legalized in Canada.
The document also states that Deloitte Canada, a consulting firm, has projected Canada’s recreational marijuana use market between C$4.9 billion to C$8.7 billion. Various other industry estimates have also placed the total market size including ancillary products and services to total more than C$20 billion.
Canada currently has 58 licensed medicinal cannabis producers and 235,621 registered patients (as of September 2017), according to Creso.
CRESO Pharma press release by Jenn Hoegg on Scribd
Editor’s note: This story has been updated to reflect a change in the location of the facility.
